ROKA 3.00 Roka Bioscience Inc $ROKA Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
ROKA 3.00 Roka Bioscience Inc $ROKA Hit a 52 week low of 2.97 Currently at 3.00 -5.34 -64.03% With a day low of 2.97 and a total volume of 2,459,200.

ROKA Roka Bioscience Inc Recent Headline News

Roka Bioscience Reports Third Quarter 2014 Financial Results
PR Newswire - Thu Nov 06, 3:01PM CST
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three months ended September 30, 2014.
ROKA: 3.00 (-5.34)

Roka Bioscience to Report Third Quarter 2014 Financial Results On November 6, 2014
PR Newswire - Thu Oct 30, 10:00AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA) , a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the third quarter of 2014 on November 6, 2014 after the close of the financial markets.
ROKA: 3.00 (-5.34)

Roka Bioscience Reports Second Quarter 2014 Financial Results
PR Newswire - Mon Aug 11, 6:00AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three and six months ended June 30, 2014.
ROKA: 3.00 (-5.34)

Roka Bioscience to Report Second Quarter 2014 Financial Results On August 11, 2014
PR Newswire - Mon Aug 04, 7:30AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the second quarter of 2014 on August 11, 2014 before the open of the financial markets.
ROKA: 3.00 (-5.34)

Roka Bioscience, Inc. (NASDAQ: ROKA) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Tue Jul 22, 9:00AM CDT
What:
ROKA: 3.00 (-5.34), NDAQ: 43.88 (-0.02)

Zacks Investment Ideas feature highlights: Tube Mogul, YuMe, CareDX, Roka Bioscience, Goldman Sachs and Terraform Power
PR Newswire - Fri Jul 18, 8:30AM CDT
Today, Zacks Investment Ideas feature highlights Features: Tube Mogul (Nasdaq:TUBE-Free Report), YuMe (NYSE:YUME-Free Report), CareDX (Nasdaq:CDNA-Free Report), Roka Bioscience (Nasdaq:ROKA-Free Report), Goldman Sachs (NYSE:GS-Free Report) and Terraform Power (Nasdaq:TERP-Free Report).
ROKA: 3.00 (-5.34)

IPO Stock Watch: Two Biotechs IPOs Price Below Range
at Investor's Business Daily - Thu Jul 17, 12:53PM CDT
Two of six biotech IPOs planned for this week launched Thursday, both pricing below their projected ranges. Roka Bioscience (ROKA) raised $60 million by offering 5 million shares at 12, though it had expected to price at 14 to 16. Roka develops food...
ROKA: 3.00 (-5.34), SAGE: 38.72 (-0.28), CDNA: 6.10 (-0.03), DOW: 49.50 (-0.31), PFNX: 8.34 (+0.15)

Roka Bioscience Announces Pricing of Initial Public Offering
PR Newswire - Thu Jul 17, 7:30AM CDT
Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the common stock is being offered by Roka Bioscience. In addition, Roka Bioscience has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price. The shares are expected to begin trading on the NASDAQ Global Market on July 17, 2014 under the ticker symbol "ROKA". The offering is expected to close on July 22, 2014, subject to customary closing conditions.
ROKA: 3.00 (-5.34)

IPO Calendar: 11 IPOs This Week Include 6 Biotechs
at Investor's Business Daily - Mon Jul 14, 1:17PM CDT
Eleven companies plan to make their IPO debuts this week, following the traditionally slow first two weeks of July. The largest initial public offering planned is TerraForm Power (TERP), an owner and operator of solar energy power plants. It's a...
ROKA: 3.00 (-5.34), SAGE: 38.72 (-0.28), TERP: 27.76 (-0.15), GLOB: 14.12 (+0.70), MTBC: 3.35 (-0.10), SUNE: 18.06 (-0.31), TUBE: 16.03 (+0.82), ABY: 32.40 (-0.08), TRUP: 6.54 (-0.21), NYLD: 48.48 (-0.70), PFNX: 8.34 (+0.15), DOW: 49.50 (-0.31)

IPO Stock Watch: Five Biotechs On Upcoming IPO Docket
at Investor's Business Daily - Fri Jul 11, 4:21PM CDT
The market for health care IPOs shows no sign of slowing. Five of nine initial public offerings slated to debut the week of July 14 are in the biotech sector. The largest of these is Roka Bioscience (ROKA), which develops food safety testing...
ROKA: 3.00 (-5.34), DOW: 49.50 (-0.31), PFNX: 8.34 (+0.15)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading